BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21279258)

  • 1. [Psychiatric and cognitive problems associated to hepatitis C and its treatment with interferon].
    Caneo R C; González T M; Repetto L PB; Soza R A
    Rev Med Chil; 2010 Nov; 138(11):1431-40. PubMed ID: 21279258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of pulmonary toxicity associated with the use of interferon therapy for hepatitis C: case report and review of the literature.
    Midturi J; Sierra-Hoffman M; Hurley D; Winn R; Beissner R; Carpenter J
    Clin Infect Dis; 2004 Dec; 39(11):1724-9. PubMed ID: 15578378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy of hepatitis C: overview.
    Lindsay KL
    Hepatology; 1997 Sep; 26(3 Suppl 1):71S-77S. PubMed ID: 9305668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The experience of interferon-based treatments for hepatitis C infection.
    Hopwood M; Treloar C
    Qual Health Res; 2005 May; 15(5):635-46. PubMed ID: 15802540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irritability rather than depression during interferon treatment is linked to increased tryptophan catabolism.
    Russo S; Kema IP; Haagsma EB; Boon JC; Willemse PH; den Boer JA; de Vries EG; Korf J
    Psychosom Med; 2005; 67(5):773-7. PubMed ID: 16204437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Side effects. Safety and effectiveness of interferon and ribavirin in HIV+ people co-infected with hepatitis C virus.
    TreatmentUpdate; 2001; 12(8):4-5. PubMed ID: 12132439
    [No Abstract]   [Full Text] [Related]  

  • 7. [Recent progress in the treatment of interferon-resistant hepatitis C].
    Kumada M
    Nihon Naika Gakkai Zasshi; 1999 Sep; 88(9):1759-62. PubMed ID: 10581760
    [No Abstract]   [Full Text] [Related]  

  • 8. [Management of adverse effects of hepatitis C treatment].
    González Ballerga E; Fernández N; Losso M
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S61-4; discussion S74-82. PubMed ID: 16862865
    [No Abstract]   [Full Text] [Related]  

  • 9. [Adverse reactions and quality of life].
    Trejo Estrada R
    Rev Gastroenterol Mex; 2002 Oct; 67 Suppl 2():S95-7. PubMed ID: 12712865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychiatric symptoms related to interferon therapy for chronic hepatitis C: clinical features and prognosis.
    Hosoda S; Takimura H; Shibayama M; Kanamura H; Ikeda K; Kumada H
    Psychiatry Clin Neurosci; 2000 Oct; 54(5):565-72. PubMed ID: 11043807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cotton-wool spots appearing during the course of treatment with interferon and ribavirin].
    Avérous K; Rocher P; Bonsch M; Le Corguillé M; Eugène C
    Gastroenterol Clin Biol; 2003 Oct; 27(10):945-6. PubMed ID: 14631312
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis C, interferon alfa, and depression.
    Zdilar D; Franco-Bronson K; Buchler N; Locala JA; Younossi ZM
    Hepatology; 2000 Jun; 31(6):1207-11. PubMed ID: 10827143
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antiviral therapy of hepatitis C].
    Erhardt A; Petry W; Ebel M; Jablonowski H; Heintges T; Häussinger D
    Z Gastroenterol; 2000 Mar; 38(3):259-69. PubMed ID: 10768250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus and depression in drug users.
    Johnson ME; Fisher DG; Fenaughty A; Theno SA
    Am J Gastroenterol; 1998 May; 93(5):785-9. PubMed ID: 9625128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating hepatitis C: the state of the art.
    Gish RG
    Gastroenterol Clin North Am; 2004 Mar; 33(1 Suppl):S1-9. PubMed ID: 15081099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukocyte and platelet lowering by some interferon types during viral hepatitis treatment.
    Toccaceli F; Rosati S; Scuderi M; Iacomi F; Picconi R; Laghi V
    Hepatogastroenterology; 1998; 45(23):1748-52. PubMed ID: 9840140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatitis B virus and celiac disease].
    Narváez Rodríguez I; Jiménez Jaén C
    Gastroenterol Hepatol; 2010 Oct; 33(8):617. PubMed ID: 20434813
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of extrahepatic manifestations associated with hepatitis C virus infection].
    Cacoub P
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B210-9. PubMed ID: 12180291
    [No Abstract]   [Full Text] [Related]  

  • 19. Widening the door: the evolution of hepatitis C treatment in patients with psychiatric disorders.
    Geppert CM; Arora S
    Hepatology; 2007 Oct; 46(4):957-9. PubMed ID: 17886300
    [No Abstract]   [Full Text] [Related]  

  • 20. Irritability: an underappreciated side effect of interferon treatment for chronic hepatitis C?
    Blacklaws H; Gardner A; Usher K
    J Clin Nurs; 2011 May; 20(9-10):1215-24. PubMed ID: 21371144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.